Welcome to our recurring pharmacy continuation education series, “Cleveland Clinic Abu Dhabi
PharmaCEries”. Our live CE events will be broadcasting regional and international speakers who will be covering trending topics in the pharmacy profession. Our events are accredited through the Accreditation Council for Pharmacy Education (ACPE) and are free to attend. These events are targeted to pharmacists and pharmacy technicians practicing in the hospital setting as well as the ambulatory setting.
17:40 – 18:00 Rania El-Lababidi Senior Manager, Pharmacy Education and Training Cleveland Clinic Abu Dhabi
18:00 – 18:30 Panel discussion (30 minutes)
Learning Objectives: At the completion of this activity, the participant will be able to –
Review the phases of vaccine development and the safety criteria.
Recognize the immunologic basis for SARS-CoV-2 vaccination and the importance of neutralizing antibodies associated with protection from infection.
Define the different platforms used to develop SARS-CoV-2 vaccines.
Assess the immunogenicity and safety data for the different vaccine candidates.
This program is being sponsored by Cleveland Clinic Abu Dhabi
Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and complies with the Accreditation Standards for continuing education activities. The Universal Activity Number for this activity is 0590-0000-21-001-L06-P. This is knowledge-based activity is developed for pharmacists for a total of 1.5 contact hour (0.15 CEU). The activity will be released March 23rd, 2021 and expires March 23rd, 2022. Financial support was not obtained for this activity and there is no registration fee. Participants will be provided with an evaluation tool and an assessment to evaluate this activity and will receive a Statement of Credit once the evaluation is completed and submitted. This information will be automatically reported to CPE Monitor for US pharmacists. Evaluations must be completed on or before April 23rd, 2021. Failure to complete the evaluation by this date will result in a loss of continuing pharmacy education credit. For additional information, contact Pharmacy Training Program PharmacyTrainingPrograms@ClevelandClinicAbuDhabi.ae.
Topic: Role of SGLT2 inhibitors in Cardiac Disorders
25th May 2021 Timings: 17:00 – 18:00hrs (GMT +4)
Dr Ruba Dajani. Pharm.D., BCPS Pharmacotherapy Specialist Cleveland Clinic Abu Dhabi
Dr William Baker Jr. Pharm.D., FCCP, FACC, FAHA Associate Professor University of Connecticut School of Pharmacy
Dr Bassam Atallah, Pharm.D, MS, FHFSA Clinical Associate Professor Pharmacotherapy Specialist Cleveland Clinic Abu Dhabi
Staff Physician, Infectious Diseases, Medical Subspecialties Institute
Cleveland Clinic Abu Dhabi
Dr. Maria Fernanda Bonilla, MD, is a Staff Physician in the Medical Subspecialties Institute at Cleveland Clinic Abu Dhabi.
Prior to joining Cleveland Clinic Abu Dhabi, Dr. Bonilla worked as a Clinical Assistant Professor of Internal Medicine at Ohio University College of Osteopathic Medicine and as an Infectious Diseases Consultant at Pinnacle Infectious Diseases in Ohio, US.
She is Board-Certified in Internal Medicine and Infectious Diseases by the American Board of Internal Medicine.
Dr. Bonilla completed Medical School at Universidad del Valle in her birth country, Colombia. She subsequently pursued her Internal Medicine residency and Infectious Diseases fellowship at the Cleveland Clinic in Cleveland, Ohio, US.
Following her training, Dr. Bonilla worked in the Northeast Ohio, Akron area for three years, where she built up a busy practice.
Dr. Bonilla resides in Abu Dhabi with her husband and their three children.
Staff Physician, Allergy ＆ Immunology, Respiratory Institute
Cleveland Clinic Abu Dhabi
Dr. Fulvio Salvo, MD, is a Staff Physician Allergy and Immunology in the Respiratory Institute at Cleveland Clinic Abu Dhabi.
Prior to joining Cleveland Clinic Abu Dhabi, Dr. Salvo had been working as a consultant physician at Arcispedale Santa Maria Nuova in Reggio Emilia, Italy. His area of interest includes recognition and treatment of acute allergic conditions such as anaphylaxis, angioedema of the airways and severe asthma.
Dr. Salvo received his medical degree from Vita-Salute San Raffaele University in Milan, Italy. He completed his residency at the same University, with a specific focus on vasculitis and other autoimmune diseases.
Dr. Salvo has a particular interest in teaching. He had joined Vita-Salute San Raffaele University first as a tutor in the courses “Medical Therapeutics” and “Immunology, Rheumatology, and Allergy” and then as an adjunct professor.
He personally developed and oversaw original research projects in different fields of medicine and co-authored multiple scientific publications on international peer-reviewed journals.
Dr. Salvo resides in Abu Dhabi with his wife and two children. He loves traveling, hiking and scuba diving. He also plays piano and likes classical music.
Dr Ruba Dajani. Pharm.D., BCPS
Pharmacotherapy Specialist Cleveland Clinic Abu Dhabi
Dr. Ruba Dajani is an Endocrinology and Internal Medicine Pharmacotherapy Specialist. She earned a Bachelor’s of Arts degree in Psychology from the George Washington University and her Doctor of Pharmacy degree from Massachusetts College of Pharmacy and Health Sciences in the United States. She subsequently completed a PGY1 Pharmacy Practice Residency at MedStar Washington Hospital Center in Washington D.C. and practiced there as a clinical pharmacist for four years prior to joining Cleveland Clinic Abu Dhabi (CCAD). Ruba is a US board certified Pharmacotherapy Specialist. At CCAD, she established the Emergency Department pharmacy service, an Endocrinology rounding service, and Internal Medicine rounding service. She is also Adjunct Faculty at the UAE University in Al-Ain. Other interests include pharmacogenomics, cardiology, infectious diseases, and burn/trauma.
Dr William Baker Jr. Pharm.D., FCCP, FACC, FAHA
Associate Professor University of Connecticut School of Pharmacy
William L. Baker, Pharm.D. is an Associate Professor of Pharmacy Practice at the University of Connecticut School of Pharmacy in Storrs, CT, USA. He has been on faculty for 12 years and joined after completing a 2-year fellowship in Cardiovascular Pharmacology & Outcomes Research. His research involves cardiovascular outcomes investigations including systematic review/meta-analysis and observational evaluations. To date, he has published nearly 170 manuscripts in peer-reviewed journals including the Journal of the American Medical Association, Journal of the American College of Cardiology, Annals of Internal Medicine, and Circulation. He has been designated a Fellow of the American College of Clinical Pharmacy, American College of Cardiology, and American Heart Association.
Dr Bassam Atallah, Pharm.D, MS, FHFSA
Clinical Associate Professor Pharmacotherapy Specialist Cleveland Clinic Abu Dhabi
Dr Atallah is the Heart and Vascular Institute pharmacotherapy specialist at Cleveland Clinic Abu Dhabi. He is a clinical associate professor at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Prior to joining Cleveland Clinic he was on faculty as Assistant Professor of Clinical Pharmacy at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) in Riyadh, Kingdom of Saudi Arabia. He is the chair of the American College of Clinical Pharmacy (ACCP) Cardiology Practice and Research Network (PRN) International Committee.
Dr. Atallah received his PharmD from Bernard J. Dunn School of Pharmacy in Virginia and completed an ASHP accredited post graduate residency at Winchester Medical Center in Virginia. Dr. Atallah is board certified in pharmacotherapy with added qualifications in Cardiology. He also holds an advanced antithrombotic management certificate from the American Society of Health-System Pharmacists. Dr Atallah is the Heart Failure Society of America (HFSA) fellow and Middle East Ambassador. He is a member of the American College of Cardiology. He also serves on the Health Authority Abu Dhabi (HAAD) subject matter experts (SME) pharmacology committee and the Emirates Heart Failure Conference Scientific Committee. He has several publications and presentations at national and international conferences.
In his current role at Cleveland Clinic Abu Dhabi, Dr Atallah established the first per protocol physician-pharmacotherapy specialist heart failure collaborative practice agreement clinic in the Middle-East Gulf region.